MedPath

齐鲁制药(海南)有限公司

Ownership
-
Established
2005-10-18
Employees
-
Market Cap
-
Website
www.qilu-hainan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

126

NMPA:126

Drug Approvals

Amisulpride Injection

Product Name
氨磺必利注射液
Approval Number
国药准字H20254415
Approval Date
Jun 3, 2025
NMPA

Micafungin Sodium for Injection

Product Name
注射用米卡芬净钠
Approval Number
国药准字H20254375
Approval Date
May 27, 2025
NMPA

Micafungin Sodium for Injection

Product Name
注射用米卡芬净钠
Approval Number
国药准字H20254376
Approval Date
May 27, 2025
NMPA

Sitagliptin and Metformin Hydrochloride Sustained-release Tablets

Product Name
西格列汀二甲双胍缓释片
Approval Number
国药准字H20253718
Approval Date
Mar 25, 2025
NMPA

Isavuconazonium Sulfate for Injection

Product Name
注射用硫酸艾沙康唑
Approval Number
国药准字H20253662
Approval Date
Mar 18, 2025
NMPA

Ritonavir Tablets

Product Name
利托那韦片
Approval Number
国药准字H20253280
Approval Date
Jan 24, 2025
NMPA

Ibrutinib Tablets

Product Name
伊布替尼片
Approval Number
国药准字H20253031
Approval Date
Jan 2, 2025
NMPA

Ibrutinib Tablets

Product Name
伊布替尼片
Approval Number
国药准字H20253032
Approval Date
Jan 2, 2025
NMPA

Apalutamide Tablets

Product Name
阿帕他胺片
Approval Number
国药准字H20249668
Approval Date
Dec 1, 2024
NMPA

Terbinafine Hydrochloride Spray

Product Name
盐酸特比萘芬喷雾剂
Approval Number
国药准字H20244832
Approval Date
Sep 10, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.